Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Pahr Therapeutics, Inc.

Pahr Therapeutics, Inc.

Stage unknownBoston, MABiotechnology
Facts
Year of incorporation
2025sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
1 rounds
  1. Feb 27, 2025
    Form D equity offering · $4.7M (form d sold) · 4 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Pahr Therapeutics, Inc. filed Form D: $4,666,668 sold of $14,000,002, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
2 officers, 3 directors
Timeline
1
  1. Jul 18, 2025
    Pahr Therapeutics, Inc. filed Form D: $4,666,668 sold of $14,000,002, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
15 observations
Every observation on this company